[i] The Happiness Research Institute, LEO Innovation Lab. World Psoriasis Happiness Report, 2017.

[ii] Lowes MA, Suarez-Farinas M, Kreuger JG. Immunology of psoriasis. Ann Rev Immunol. 2014; 32:227-35.

[iii] Moeller AH, Ernstoft S, Vinding GR, Jernec BCE. A systematic literature review to compare quality of life in psoriasis with other chronic diseases using EQ-SD-derived utility values. Patient Relat Outcome Meas. 2015; 6:166-77.

[iv] Ferreira BI, Abreu JL, Reis JP, Figueiredo AM. Psoriasis and associated psychiatric disorders: a systematic review on etiopathogenesis and clinical correlation. J. Clin Aesthet Dermatol 2016; 9:36-43.

[v] The International Federation of Psoriasis Associations. Available via https://ifpa-pso.com/about/. Accessed August 2017.

[vi] WHO, Resolution WHA67.9. Geneva, World Health Organization, 2014. http://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R9-en.pdf. Accessed August 2017.



MAT-12602